Trust linked to AEHR (NASDAQ: AEHR) director sells 13,998 shares

Rhea-AI Filing Summary

Aehr Test Systems director Rhea J. Posedel reported an insider sale of common stock through a trust associated with her. On February 13, 2026, the trust sold 13,998 shares of Aehr Test Systems common stock in an open-market transaction at $30.0151 per share.

After this transaction, the trust continued to hold 456,979 shares indirectly. Posedel also directly held 71,163 shares, and this direct amount includes shares subject to unvested restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POSEDEL RHEA J

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CA 94539

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		S		13,998	D	$30.0151	456,979	I	By Trust
Common Stock								71,163(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AEHR director Rhea J. Posedel report?

Rhea J. Posedel reported an insider sale of Aehr Test Systems common stock. A trust associated with her sold 13,998 shares on February 13, 2026, at $30.0151 per share in an open-market transaction, while retaining a significant indirect share position afterward.

How many AEHR shares did the trust linked to Rhea J. Posedel sell?

The trust associated with Rhea J. Posedel sold 13,998 shares of Aehr Test Systems common stock. The sale occurred on February 13, 2026, as an open-market transaction, with a reported sale price of $30.0151 per share according to the Form 4 filing details.

What price was received for the AEHR shares sold in the reported insider trade?

The reported sale price for the Aehr Test Systems shares was $30.0151 per share. This price applied to 13,998 common shares sold by a trust associated with director Rhea J. Posedel in an open-market transaction dated February 13, 2026, under the Form 4 filing.

How many AEHR shares does the trust hold after the reported sale?

Following the transaction, the trust held 456,979 Aehr Test Systems shares indirectly. This post-transaction balance reflects the remaining indirect ownership after selling 13,998 common shares, as shown in the Form 4 table for non-derivative securities beneficially owned.

What is Rhea J. Posedel’s direct AEHR share ownership after this Form 4 filing?

After the reported transaction, Rhea J. Posedel directly owned 71,163 shares of Aehr Test Systems common stock. The filing notes that this direct amount includes shares subject to unvested restricted stock units, which are equity awards that have not yet fully vested.

Does the AEHR Form 4 mention restricted stock units held by Rhea J. Posedel?

Yes. The Form 4 states that the amount reported in Posedel’s direct holdings includes shares subject to unvested restricted stock units. This means part of her 71,163 directly held Aehr Test Systems shares comes from equity awards that will vest over time.